Business Context and Reporting Period
Company: Fresenius Medical Care AG & Co. KGaA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: February 24, 2016
Reporting Period: Fourth Quarter and Full Year 2015
This filing announces the issuance of an Investor News release containing earnings results for the fourth quarter and the twelve months ended December 31, 2015. The detailed financial data is contained in Exhibit 99.1, which is referenced but not included in the text of this Form 6-K.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document serves as a cover sheet referencing an attached Investor News release (Exhibit 99.1) where these figures are detailed.
The company utilizes the following non-GAAP financial measures to supplement GAAP results:
- EBITDA: Operating income excluding interest, taxes, depreciation, and amortization.
- Free Cash Flow: Used to enhance understanding of financial performance and prospects.
Reconciliations between these non-GAAP measures and GAAP measures are located in the attached Investor News and the Cash Flow Statement.
Material Changes
The filing text does not provide specific data regarding material changes versus prior comparable periods. Investors must refer to the attached Exhibit 99.1 for comparative analysis.
Guidance, Outlook, and Risks
Management Commentary: Management states that the inclusion of non-GAAP measures provides consistency and comparability with prior periods. These measures are intended to enhance the user's understanding of current performance and future prospects but should not be considered superior to GAAP measures.
Legal Disclaimer: The attached Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section. It shall not be incorporated by reference in any other filing.
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this Form 6-K.
Investor Verification Checklist
- Verify the specific revenue, EBITDA, and free cash flow figures in the attached Exhibit 99.1 (Investor News).
- Review the reconciliation tables in Exhibit 99.1 to understand the adjustments between GAAP and non-GAAP measures.
- Confirm the full-year 2015 performance against the company's prior guidance (if available in the full report).
- Note that the Form 6-K text itself contains no numerical financial data.